Epilepsy Devices Market Size, Share, Growth Analysis, By Product Type(Conventional Devices (Monitoring Devices [EEG devices {Standard EEG devices, Video EEG devices, Other/Ambulatory EEG devices}, EMG devices), By End-users(Hospitals, Neurology Centers, Ambulatory Surgery Centers & Clinics, Diagnostic Centers), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2742 | Region: Global | Published Date: July, 2027
Pages: 219 |Tables: 92 |Figures: 76

Epilepsy Devices Market Insights

Global Epilepsy Devices Market size was valued at USD 1.30 billion in 2022 and is poised to grow from USD 1.42 billion in 2023 to USD 2.87 billion by 2031, growing at a CAGR of 9.2% during the forecast period (2024-2031). 

The Global Epilepsy Devices Market is experiencing considerable growth driven by means of elements which includes increasing incidence of epilepsy, growing focus, and improvements in clinical generation. The demand for epilepsy gadgets, consisting of implantable neurostimulators and wearable seizure monitoring gadgets, is on the upward thrust. These devices purpose to decorate seizure detection, control, and affected person results. However, challenges like excessive costs, limited compensation guidelines, and the need for skilled experts avoid market enlargement. North America dominates the marketplace, even as the Asia-Pacific vicinity is witnessing great growth, driven through enhancing healthcare infrastructure and developing consciousness of epilepsy management. Key tendencies include continuous innovation in device generation and a focus on affected person-centric answers.

Market Snapshot - 2024-2031

Global Market Size

USD 1.30 billion

Largest Segment

Hospitals

Fastest Growth

Hospitals

Growth Rate

9.2% CAGR

Epilepsy Devices Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Epilepsy Devices Market Segmental Analysis

The global epilepsy devices market is segmented based on product type, end-users, and region. Based on product type, the market is segmented into Conventional Devices (Monitoring Devices [EEG devices {Standard EEG devices, Video EEG devices, Other/Ambulatory EEG devices}, EMG devices, MEG devices, other monitoring devices], Deep Brain Stimulation Devices), and wearable devices. Based on End-users, the market is segmented into, Hospitals, Neurology Centers, Ambulatory Surgery Centers & Clinics, Diagnostic Centers, Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. 

Analysis by Product Type 

EMG devices have been a dominant device segment within the Epilepsy Devices Market. These devices, together with vagus nerve stimulators (VNS) and responsive neurostimulation devices, are properly-set up and broadly used for handling epilepsy by way of modulating neural hobby. They have demonstrated effectiveness in reducing seizure frequency and improving patient results. 

Wearable devices are probably to be the fastest-growing segment. Advancements in wearable generation have brought about the development of non-invasive devices that may continuously screen and document physiological records, offering valuable insights into seizure styles. The developing call for for patient-centric answers, faraway monitoring, and the capacity for early detection make wearable gadgets a key driver for marketplace increase. 

Analysis by End-User 

According to end-user segmentation, the global market in 2023 was categorized into hospitals & clinics, home care settings, and other sectors. Among these, hospitals and clinics emerged as the primary consumers of epilepsy monitoring and emergency medical services. Ambulatory Surgical Centers have notably surfaced as a rapidly expanding secondary option for EEG monitoring, while diagnostic centers have adapted to this trend. Additionally, home care settings have become increasingly viable for long-term solutions in epilepsy management. 

Epilepsy Devices Market By End User

To get detailed analysis on other segments, Request For Free Sample Report

Epilepsy Devices Market Regional Insights

North America has historically dominated the Epilepsy Devices Market. Factors including well-mounted healthcare infrastructure, excessive healthcare expenditure, and early adoption of advanced scientific technology contribute to the market's dominance in this location.

Asia-Pacific is expected to be the quickest-developing market. Increasing focus on epilepsy management, enhancing healthcare infrastructure, and a developing population with epilepsy make contributions to the marketplace's growth in this location. Additionally, rising investments in healthcare and a focal point on technological advancements drive marketplace expansion.

Epilepsy Devices Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Epilepsy Devices Market Dynamics

Drivers

Increasing Prevalence Of Epilepsy Worldwide

  • The increasing prevalence of epilepsy worldwide has substantially elevated the patient pool, fostering demand for advanced medical interventions. Technological advancements in epilepsy devices, consisting of implantable neurostimulators and responsive neurostimulation, have improved the control of seizures, improving affected person outcomes. Moreover, a developing cognizance of epilepsy and the importance of early prognosis and intervention has undoubtedly encouraged marketplace dynamics.

Restraints

High Cost Associated with Advanced Epilepsy Devices

  • One of the primary market restraints is the excessive fee associated with superior epilepsy gadgets, making them less available for a giant part of the populace, especially in areas with limited healthcare sources. Additionally, compensation guidelines and insurance coverage may also pose boundaries to sizable adoption. The want for professional professionals for the right implementation and tracking of these gadgets is every other constraint, highlighting the significance of comprehensive healthcare infrastructure.

Request Free Customization of this report to help us to meet your business objectives.

Epilepsy Devices Market Competitive Landscape

The aggressive environment of the Epilepsy Devices marketplace is dynamic and is characterised by using the presence of numerous key gamers engaged in a dynamic and innovative enterprise. The companies often focus on strategic partnerships, collaborations, and product improvements to reinforce their marketplace positions. With an increasing emphasis on customized medicine and technological improvements, the competitive panorama is marked through a continuous force for innovation to fulfill the evolving desires of epilepsy sufferers.

Top Player’s Company Profiles

  • Medtronic plc
  • Boston Scientific Corporation
  • LivaNova PLC
  • Abbott Laboratories
  • Natus Medical Incorporated
  • Masimo Corporation
  • Compumedics Limited
  • Cadwell Industries
  • Empatica, Inc.
  • ADInstruments
  • Neuropace, Inc.
  • Blackfount Technologies, Inc.
  • NeuroSweet
  • BrainDx Limited
  • NeuroSky Inc.
  • BrainCo
  • Spire Health
  • Epibright LLC
  • Neurolief, Inc.
  • NeuroBoosted Technologies Corporation

Recent Developments

  • October 2023: According to a recent take a look at, in cases wherein conventional remedies show ineffective, an experimental drug referred to as XEN1101 demonstrates the potential to decrease seizure frequency by using over 50% in particular individuals, and in a few times, it completely gets rid of seizures.
  • January 2024: Akumentis Healthcare announced the advent of a medicine for epilepsy treatment. The Mumbai-based organization has unveiled Clasepi, a prescription cannabidiol (CBD) authorised by the Drug Controller General of India (DCGI).

Epilepsy Devices Key Market Trends

  • Rising Emphasis On Wearable Seizure Monitoring Devices: The increasing emphasis on wearable seizure tracking gadgets, reflecting a shift closer to patient-centric and non-invasive solutions for non-stop monitoring. Additionally, there's a developing consciousness on responsive neurostimulation technologies, providing real-time adaptive responses to detected odd mind interest. Personalized remedy is turning into a key trend, with a focus on tailoring remedy approaches to character affected person profiles.

Epilepsy Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

Global Epilepsy Devices market analysis exhibits a dynamic market with a number of standout tendencies and difficulties. The marketplace is driven through a surge in epilepsy prevalence, prompting calls for superior solutions. Technological improvements in implantable neurostimulators and responsive neurostimulation gadgets beautify seizure management. However, the market faces constraints because of high device costs, restricted compensation, and the need for skilled specialists. Implantable neurostimulators dominate the product panorama. North America holds marketplace management, driven via robust healthcare infrastructure. The Asia-Pacific region is the quickest-growing marketplace, fueled through increasing attention and healthcare investments. Key tendencies contain wearable seizure tracking devices, personalised medicinal drugs, and the integration of digital health technology, reflecting a dynamic panorama addressing evolving patient wishes.

Report Metric Details
Market size value in 2022 USD 1.30 billion
Market size value in 2031 USD 2.87 billion
Growth Rate 9.2%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product Type
    • Conventional Devices (Monitoring Devices [EEG devices {Standard EEG devices, Video EEG devices, Other/Ambulatory EEG devices}, EMG devices, MEG devices, Other monitoring devices], Deep Brain Stimulation Devices), Wearable Devices
  • End-users
    • Hospitals, Neurology Centers, Ambulatory Surgery Centers & Clinics, Diagnostic Centers, Home Care Settings
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Medtronic plc
  • Boston Scientific Corporation
  • LivaNova PLC
  • Abbott Laboratories
  • Natus Medical Incorporated
  • Masimo Corporation
  • Compumedics Limited
  • Cadwell Industries
  • Empatica, Inc.
  • ADInstruments
  • Neuropace, Inc.
  • Blackfount Technologies, Inc.
  • NeuroSweet
  • BrainDx Limited
  • NeuroSky Inc.
  • BrainCo
  • Spire Health
  • Epibright LLC
  • Neurolief, Inc.
  • NeuroBoosted Technologies Corporation
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Epilepsy Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Epilepsy Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Epilepsy Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Epilepsy Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Epilepsy Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Epilepsy Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Epilepsy Devices Market size was valued at USD 1.30 billion in 2022 and is poised to grow from USD 1.42 billion in 2023 to USD 2.87 billion by 2031, growing at a CAGR of 9.2% during the forecast period (2024-2031). 

The aggressive environment of the Epilepsy Devices marketplace is dynamic and is characterised by using the presence of numerous key gamers engaged in a dynamic and innovative enterprise. The companies often focus on strategic partnerships, collaborations, and product improvements to reinforce their marketplace positions. With an increasing emphasis on customized medicine and technological improvements, the competitive panorama is marked through a continuous force for innovation to fulfill the evolving desires of epilepsy sufferers. 'Medtronic plc', 'Boston Scientific Corporation', 'LivaNova PLC', 'Abbott Laboratories', 'Natus Medical Incorporated', 'Masimo Corporation', 'Compumedics Limited', 'Cadwell Industries', 'Empatica, Inc.', 'ADInstruments', 'Neuropace, Inc.', 'Blackfount Technologies, Inc.', 'NeuroSweet', 'BrainDx Limited', 'NeuroSky Inc.', 'BrainCo', 'Spire Health', 'Epibright LLC', 'Neurolief, Inc.', 'NeuroBoosted Technologies Corporation'

The increasing prevalence of epilepsy worldwide has substantially elevated the patient pool, fostering demand for advanced medical interventions. Technological advancements in epilepsy devices, consisting of implantable neurostimulators and responsive neurostimulation, have improved the control of seizures, improving affected person outcomes. Moreover, a developing cognizance of epilepsy and the importance of early prognosis and intervention has undoubtedly encouraged marketplace dynamics.

Rising Emphasis On Wearable Seizure Monitoring Devices: The increasing emphasis on wearable seizure tracking gadgets, reflecting a shift closer to patient-centric and non-invasive solutions for non-stop monitoring. Additionally, there's a developing consciousness on responsive neurostimulation technologies, providing real-time adaptive responses to detected odd mind interest. Personalized remedy is turning into a key trend, with a focus on tailoring remedy approaches to character affected person profiles.

North America has historically dominated the Epilepsy Devices Market. Factors including well-mounted healthcare infrastructure, excessive healthcare expenditure, and early adoption of advanced scientific technology contribute to the market's dominance in this location.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Epilepsy Devices Market

Report ID: SQMIG35A2742

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE